This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

EPO publishes decision to revoke Boston Scientific’s stent patent

( February 24, 2025, 12:05 GMT | Official Statement) -- MLex Summary: The European Patent Office has today published its decision to revoke Boston Scientific’s patent for a stent design aimed at reducing inflammation, following a challenge by Biotronik. The ruling, originally made in November last year, found the invention lacked an inventive step, as similar designs were already disclosed in prior art. Boston Scientific’s attempts to amend the claims were also rejected.The decision is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents